[HTML][HTML] Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment

M Zhang, W Hu, C Cai, Y Wu, J Li, S Dong - Materials Today Bio, 2022 - Elsevier
Inflammatory arthritis is a major cause of disability in the elderly. This condition causes joint
pain, loss of function, and deterioration of quality of life, mainly due to osteoarthritis (OA) and …

Novel nano therapeutic materials for the effective treatment of rheumatoid arthritis-recent insights

K Janakiraman, V Krishnaswami, V Rajendran… - Materials Today …, 2018 - Elsevier
Rheumatoid arthritis (RA) is the most common complex multifactorial joint related
autoimmune inflammatory disease with unknown etiology accomplished with increased …

Stimuli‐Sensitive Nanotherapies for the Treatment of Osteoarthritis

Z Wang, S Wang, K Wang, X Wu… - Macromolecular …, 2021 - Wiley Online Library
Osteoarthritis (OA) is a common chronic inflammatory disease in the joints. It is one of the
leading causes of disability with increasing morbidity, which has become one of the serious …

Recent approaches for targeted drug delivery in rheumatoid arthritis diagnosis and treatment

S Pirmardvand Chegini, J Varshosaz… - Artificial cells …, 2018 - Taylor & Francis
Rheumatoid arthritis (RA) is a chronic inflammatory disease with complex pathology
characterized by inflammation of joints, devastation of the synovium, pannus formation …

Stimulus‐Responsive Drug Delivery Nanoplatforms for Osteoarthritis Therapy

Q Jiang, S Zhang - Small, 2023 - Wiley Online Library
Osteoarthritis (OA) is one of the most prevalent age‐related degenerative diseases. With an
increasingly aging global population, greater numbers of OA patients are providing clear …

Nanotechnology application in drug delivery to osteoarthritis (OA), rheumatoid arthritis (RA), and osteoporosis (OSP)

M Rabiei, S Kashanian, SS Samavati… - Journal of drug delivery …, 2021 - Elsevier
Nanoparticles (NPs) show great promise as tools for designing formulations capable of
meeting the challenge of targeted and non-targeted drug delivery to bone and cartilage …

Nanomedicine–advantages for their use in rheumatoid arthritis theranostics

S Xiao, Y Tang, Z Lv, Y Lin, L Chen - Journal of controlled release, 2019 - Elsevier
Rheumatoid arthritis (RA) is an autoimmune disease accompanies with synovial
inflammation and progressive bone destruction. Currently, anti-rheumatic drugs need high …

Targeted treatment for osteoarthritis: drugs and delivery system

L Mao, W Wu, M Wang, J Guo, H Li, S Zhang, J Xu… - Drug …, 2021 - Taylor & Francis
The management of osteoarthritis (OA) is a clinical challenge due to the particular avascular,
dense, and occluded tissue structure. Despite numerous clinical reports and animal studies …

[HTML][HTML] Intra-articular nanoparticles based therapies for osteoarthritis and rheumatoid arthritis management

J Wen, H Li, H Dai, S Hua, X Long, H Li, S Ivanovski… - Materials Today Bio, 2023 - Elsevier
Osteoarthritis (OA) and rheumatoid arthritis (RA) are chronic and progressive inflammatory
joint diseases that affect a large population worldwide. Intra-articular administration of …

Biomimetic and bioinspired intervention strategies for the treatment of rheumatoid arthritis

Y Han, X Pang, G Pi - Advanced Functional Materials, 2021 - Wiley Online Library
Rheumatoid arthritis (RA) affects the joints and extra‐articular organs and poses a
significant health care problem in the modern era. Although current standard treatment …